BiotechTV - News

Marea Therapeutics today announced acceptance of a late-breaker at #EASCongress2025 for its ANGPTL4 inhibitor - believed to be the first ever clinical data presented for this lipid lowering target

Apr 15, 2025
Ask episode
Chapters
Transcript
Episode notes